InvestorsHub Logo
Followers 1025
Posts 51730
Boards Moderated 1
Alias Born 06/26/2007

Re: None

Tuesday, 03/03/2020 2:10:24 PM

Tuesday, March 03, 2020 2:10:24 PM

Post# of 19459
Tomorrow GOVX presents (COVID-19) update

During his second presentation on March 4, entitled Development of Single Dose Vaccines for Emerging Infectious Diseases Using a Novel MVA Platform, Dr. Guirakhoo will discuss the Company’s design of MVA-VLP and non-VLP vaccines for Zika, Ebola, Marburg and Lassa fever vaccines, as well as results from efficacy studies in animal challenge models. During this presentation, Dr. Guirakhoo also expects to give a current update on the Company’s collaboration with BravoVax, based in Wuhan, China, on use of GeoVax’s vaccine technology platform and expertise to develop a vaccine for prevention/control of the novel coronavirus disease (COVID-19).
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GOVX News